BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BioMarin Pharmaceutical Inc. (BioMarin or 'the company') is a biotechnology company, that is engaged in development and commercialization of biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), achondroplasia, phenylketonuria (PKU), late infantile neuronal ceroid lipofuscinosis (CLN2), and hemophilia A. BioMarin markets its products under the brands, BioMarin, Brineura, Kuvan, Naglazyme, Palynziq, Roctavian, Vimizim, Voxzogo, and Aldurazyme. It operates in the US, Europe, Latin America, and other regions of the world. The company is headquartered in San Rafael, California, the US.Scope
- Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- BioMarin Pharmaceutical Inc.: Company Overview
- BioMarin Pharmaceutical Inc.: Overview and Key Facts
- BioMarin Pharmaceutical Inc.: Overview
- BioMarin Pharmaceutical Inc.: Key Facts
- BioMarin Pharmaceutical Inc.: Key Employees
- BioMarin Pharmaceutical Inc.: Key Employee Biographies
- BioMarin Pharmaceutical Inc.: Major Products and Services
- BioMarin Pharmaceutical Inc.: Management Statement
- BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
- BioMarin Pharmaceutical Inc.: Key Competitors
- BioMarin Pharmaceutical Inc.: Company Analysis
- BioMarin Pharmaceutical Inc.: Business Description
- BioMarin Pharmaceutical Inc.: SWOT Analysis
- BioMarin Pharmaceutical Inc.: SWOT Overview
- BioMarin Pharmaceutical Inc.: Strengths
- BioMarin Pharmaceutical Inc.: Weaknesses
- BioMarin Pharmaceutical Inc.: Opportunities
- BioMarin Pharmaceutical Inc.: Threats
- BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
- BioMarin Pharmaceutical Inc.: Financial Deals Overview
- BioMarin Pharmaceutical Inc.: Targets and Partners
- BioMarin Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
- BioMarin Pharmaceutical Inc.: Capital Raising
- BioMarin Pharmaceutical Inc.: Partnership
- BioMarin Pharmaceutical Inc.: Divestments
- BioMarin Pharmaceutical Inc.: Private Equity and Ownership
- BioMarin Pharmaceutical Inc.: Recent Developments
- BioMarin Pharmaceutical Inc.: News and Events Summary
- BioMarin Pharmaceutical Inc.: Business Expansion
- BioMarin Pharmaceutical Inc.: Corporate Governance
- BioMarin Pharmaceutical Inc.: Financial Deals
- BioMarin Pharmaceutical Inc.: Financial Performance
- BioMarin Pharmaceutical Inc.: Market Developments
- BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
- BioMarin Pharmaceutical Inc.: Research & Development
- BioMarin Pharmaceutical Inc.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: BioMarin Pharmaceutical Inc.: Key Facts
- Table 2: BioMarin Pharmaceutical Inc.: Key Employees
- Table 3: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
- Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
- Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 7: BioMarin Pharmaceutical Inc.: Targets and Partners
- Table 8: BioMarin Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
- Table 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 13: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Table 14: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Table 15: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
- Table 16: BioMarin Pharmaceutical Inc.: News and Events Summary
- Table 17: BioMarin Pharmaceutical Inc.: Business Expansion
- Table 18: BioMarin Pharmaceutical Inc.: Corporate Governance
- Table 19: BioMarin Pharmaceutical Inc.: Financial Deals
- Table 20: BioMarin Pharmaceutical Inc.: Financial Performance
- Table 21: BioMarin Pharmaceutical Inc.: Market Developments
- Table 22: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
- Table 23: BioMarin Pharmaceutical Inc.: Research & Development
- Table 24: BioMarin Pharmaceutical Inc.: Strategy and Operations
- Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 3: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 4: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 5: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 6: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Figure 7: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Figure 8: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 9: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
